Aptus Capital Advisors LLC bought a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 100,882 shares of the financial services provider's stock, valued at approximately $18,716,000.
A number of other large investors have also bought and sold shares of MRSH. Numerai GP LLC increased its position in shares of Marsh & McLennan Companies by 966.2% during the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider's stock worth $7,501,000 after purchasing an additional 33,729 shares during the last quarter. Swiss Life Asset Management Ltd increased its position in shares of Marsh & McLennan Companies by 9.5% during the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider's stock worth $24,960,000 after purchasing an additional 11,648 shares during the last quarter. Barclays PLC increased its position in shares of Marsh & McLennan Companies by 41.7% during the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider's stock worth $443,844,000 after purchasing an additional 647,987 shares during the last quarter. Sarasin & Partners LLP increased its position in shares of Marsh & McLennan Companies by 0.9% during the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider's stock worth $173,411,000 after purchasing an additional 8,283 shares during the last quarter. Finally, Brown Brothers Harriman & Co. increased its position in shares of Marsh & McLennan Companies by 26.4% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 136,179 shares of the financial services provider's stock worth $27,444,000 after purchasing an additional 28,419 shares during the last quarter. 87.99% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of equities analysts have weighed in on MRSH shares. Keefe, Bruyette & Woods boosted their price target on Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a "market perform" rating in a research report on Friday, April 17th. Weiss Ratings downgraded Marsh & McLennan Companies from a "hold (c)" rating to a "hold (c-)" rating in a research report on Monday, May 11th. Mizuho lowered their price target on Marsh & McLennan Companies from $199.00 to $193.00 and set a "neutral" rating on the stock in a research report on Monday, April 13th. Citigroup raised Marsh & McLennan Companies from a "neutral" rating to a "buy" rating and set a $200.00 price target on the stock in a research report on Wednesday, May 6th. Finally, Wells Fargo & Company lowered their price target on Marsh & McLennan Companies from $203.00 to $178.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 9th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $200.19.
Check Out Our Latest Report on MRSH
Insider Activity at Marsh & McLennan Companies
In other news, CEO John Q. Doyle sold 16,656 shares of the company's stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the transaction, the chief executive officer owned 116,811 shares of the company's stock, valued at approximately $18,889,506.81. This represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company's stock.
Marsh & McLennan Companies Stock Down 0.0%
Marsh & McLennan Companies stock opened at $168.67 on Monday. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $220.32. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. The company has a market capitalization of $81.49 billion, a PE ratio of 21.08, a PEG ratio of 2.46 and a beta of 0.62.
Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last posted its earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, beating the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The company had revenue of $7.30 billion for the quarter. The firm's revenue for the quarter was up 7.6% compared to the same quarter last year. Research analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current fiscal year.
Marsh & McLennan Companies Profile
(
Free Report)
Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
See Also
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.